The DOI matches its OpenAlex record; 28 of the 28 references it cites were found in a registry or an index.
Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression
Abstract
We assessed the effects of 78 potential chemopreventive agents in the F344 rat using two assays in which the inhibition of carcinogen-induced aberrant crypt foci (ACF) in the colon was the measure of efficacy. In both assays ACF were induced by the carcinogen azoxymethane (AOM) in F344 rats by two sequential weekly injections at a dose of 15 mg/kg. Two weeks after the last AOM injection, animals were evaluated for the number of aberrant crypts detected in methylene blue stained whole mounts of rat colon. In the initiation phase protocol agents were given during the period of AOM administration, whereas in the post-initiation assay the chemopreventive agent was introduced during the last 4 weeks of an 8 week assay, a time when ACF had progressed to multiple crypt clusters. The agents were derived from a priority listing based on reports of chemopreventive activity in the literature and/or efficacy data from in vitro models of carcinogenesis. During the initiation phase carboxyl amidoimidazole, p-chlorphenylacetate, chlorpheniramine maleate, D609, diclofenac, etoperidone, eicosatetraynoic acid, farnesol, ferulic acid, lycopene, meclizine, methionine, phenylhexylisothiocyanate, phenylbutyrate, piroxicam, 9-cis-retinoic acid, S-allylcysteine, taurine, tetracycline and verapamil were strong inhibitors of ACF. During the post-initiation phase aspirin, calcium glucarate, ketoprofen, piroxicam, 9-cis-retinoic acid, retinol and rutin inhibited the outgrowth of ACF into multiple crypt clusters. Based on these data, certain phytochemicals, antihistamines, non-steroidal anti-inflammatory drugs and retinoids show unique preclinical promise for chemoprevention of colon cancer, with the latter two drug classes particularly effective in the post-initiation phase of carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tomatoes, Tomato-Based Products, Lycopene, and Cancer: Review of the Epidemiologic Literature
Giovannucci, E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.317 · Cited by 1,472
Gann, P. H., Ma, J., Giovannucci, E. L., Willett, W. C., Sacks, F. M., Hennekens, C. H., & Stampfer, M. J. (1999) · PubMed · Cited by 775
Aspirin and the potential role of prostaglandins in colon cancer.
Marnett, L. J. (1992) · PubMed · Cited by 678
Aberrant Crypt Foci of the Colon as Precursors of Adenoma and Cancer
Takayama, T., Katsuki, S., Takahashi, Y., Ohi, M., Nojiri, S., Sakamaki, S., Kato, J., Kogawa, K., Miyake, H., & Niitsu, Y. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810293391803 · Cited by 594
Tanaka, T., Kojima, T., Kawamori, T., Wang, A., Suzui, M., Okamoto, K., & Mori, H. (1993) · Carcinogenesis · doi:10.1093/carcin/14.7.1321 · Cited by 333
Aberrant crypts: potential preneoplastic lesions in the murine colon.
McLellan, E. A., & Bird, R. P. (1988) · PubMed · Cited by 304
Reduced Risk of Large-Bowel Adenomas Among Aspirin Users
Greenberg, E. R., Baron, J. A., D. H., F., Mandel, J. S., & Haile, R. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.11.912 · Cited by 293
Samaha, H. S., Kelloff, G. J., Steele, V. E., Rao, C. V., & Reddy, B. S. (1997) · PubMed · Cited by 292
Self-citationSomatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.
Smith, A. J., Štern, H., Penner, M., Hay, K. D., Mitri, A., Bapat, B. V., & Gallinger, S. (1994) · PubMed · Cited by 285
Sumiyoshi, H., & Wargovich, M. J. (1990) · PubMed · Cited by 269
Self-citationChemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity.
Yu, R., Mandlekar, S., Harvey, K. J., Ucker, D. S., & KONG, A. (1998) · PubMed · Cited by 254
Wargovich, M. J., Chen, C., Jimenez, A., Steele, V. E., Velasco, M. A. D., Stephens, L. C., Price, R., Gray, K., & Kelloff, G. J. (1996) · PubMed · Cited by 184
Self-citationPhenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa
Nucci, M. R., Robinson, C., Longo, P. A., Campbell, P. A., & Hamilton, S. R. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90230-6 · Cited by 132
Rp, B., Ea, M., & Wr, B. (1989) · PubMed · Cited by 114
The identification of monoclonality in human aberrant crypt foci.
Siu, I. M., Robinson, D. R., Schwartz, S., Kung, H.-J., Pretlow, T. G., Petersen, R. B., & Pretlow, T. P. (1999) · PubMed · Cited by 107
Low-Dose Isotretinoin Versus -Carotene to Prevent Oral Carcinogenesis: Long-term Follow-up
Papadimitrakopoulou, V. A., Hong, W. K., Lee, J. S., Lippman, S. M., Martin, J. W., Lee, J. J., & Batsakis, J. G. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.3.257 · Cited by 94
Wargovich, M. J., Chen, C. D., Harris, C., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600415 · Cited by 93
Self-citationGore, S. D., Samid, D., & Weng, L. J. (1997) · PubMed · Cited by 74
Retinoid-interferon therapy of solid tumors
Lippman, S. M., Lotan, R., & Schleuniger, U. (1997) · International Journal of Cancer · Cited by 52
Phase I trial of 9-cis retinoic acid in adults with solid tumors.
Kurie, J. M., Lee, J. S., Griffin, T., Lippman, S. M., Drum, P., Thomas, M. P., Weber, C., Bader, M., Massimini, G., & Hong, W. K. (1996) · PubMed · Cited by 51
Roncucci, L., Pedroni, M., Fante, R., et al. (1993) · PubMed · Cited by 44
Okonogi, H., Ushijima, T., Shimizu, H., Sügimura, T., & Nagao, M. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04505-3 · Cited by 37
Huang, Q. M., Lawson, T. A., Chung, F., Morris, C. R., & S.Mervish, S. (1993) · Carcinogenesis · doi:10.1093/carcin/14.4.749 · Cited by 33
Kochevar, I. E., Moran, M. N., Lyon, N., Flotte, T. J., Siebert, E. P., & Gange, R. W. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12462804 · Cited by 32
Hiroi, T., Ohishi, N., Imaoka, S., Yabusaki, Y., Fukui, H., & Funae, Y. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24518-9 · Cited by 26
Medina, M. Á., de Veas, R. G., Morata, P., Lozano, J., & Sánchez‐Jiménez, F. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00668208 · Cited by 22
GÓMEZ-FABRE, P. M., de Pedro, E., Medina, M. Á., de Castro, I. N., & Márquez, J. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04591-0 · Cited by 17
H 1 antihistamines, cytochrome P450 and multidrug resistance: Is there a link?
Rihoux, J., & --, J. M.-K. R. (1999) · Inflammation Research · doi:10.1007/s000110050411 · Cited by 3
Cited by
Ferulic acid: pharmaceutical functions, preparation and applications in foods
Ou, S., & Kwok, K. (2004) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.1873 · Cited by 869
Bile acids as carcinogens in human gastrointestinal cancers
Bernstein, H., Bernstein, C., Payne, C. M., Dvorakova, K., & Garewal, H. (2005) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.08.001 · Cited by 611
A Review of the Effects and Mechanisms of Polyphenolics in Cancer
Nichenametla, S. N., Taruscio, T. G., Barney, D. L., & Exon, J. H. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390591000541 · Cited by 444
Folate and colorectal cancer: An evidence‐based critical review
Kim, Y. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600191 · Cited by 419
Role of Folate in Colon Cancer Development and Progression
Kim, Y.-I. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.11.3731s · Cited by 386
Metadata
- Authors
- Wargovich, M. J., Jimenez, A., McKee, K., Steele, V. E., Velasco, M. A. D., Woods, J., Price, R. E., Gray, K. N., & Kelloff, G. J.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press
- Published
- 2000-06-01
- Volume
- 21
- Issue
- 6
- Pages
- 1149-1155
- ISSN
- 0143-3334 (ISSN-L)
- OpenAlex
- W1998761065
- Cited by
- 266
- References
- 28
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.